Tianjin Pharma DRT (SH600329)
Group Profile
Heritage of Ingenuity
Group News
Health Self-Check
Health Guide
中文
中文
English
search
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Contact Us
Tianjin Pharma DRT (SH600329)
35.17
+0.35 +1.01%
中文
English
Home Page
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Display
Heritage of Ingenuity
Product Center
Product Family
Products and Services
Group News
Health Guide
Health Information
Media Coverage
Investor Relations
Stock Information
Company Announcements
Investor Contact
集团党建
党建新闻
执纪监督
Join Us
Talent Concept
Recruitment Information
Contact Us
Online Mall
Investor Relations
Investor Contact
Home Page
Investor Relations
Investor Contact
Stock Information
Company Announcements
Investor Contact
Hotline:
022-27020892
Investor's Email:
drt600329@163.com
Investor Protection:
http://www.isc.com.cn/
We are the Leader of Chinese Medicine and Striving to Become a Leader in Innovative Medicine in China
Home Page
>
Investor Relations
>
Investor Contact